References
- Petty T. Adult respiratory distress syndrome. Synopsis of Clinical Pulmonary Disease, RS Mitchell, TL Petty, MI Schwartz. Mosby, Washington, DC 1989
- Weiland JE, Davis WB, Holter JF. Lung neutrophils in the adult respiratory distress syndrome: clinical and pathological significance. Am Rev Respir Dis. 1986; 133: 218–225
- Jacobs RF, Keil DP, Balk RA. Alveolar macrophage function in a canine model of endotoxin-induced lung injury. Am Rev Respir Dis. 1986; 134: 745–751
- Ognibene FP, Martin SE, Parker T. Adult respiratory distress syndrome in patients with severe neutropenia. New Engl J Med. 1986; 315: 547–551
- Chauncey JB, Peters-Gordon M, Simon RH. Arachidonic acid metabolism by rat alveolar epithelial cells. Lab Invest. 1988; 58: 133
- Liesch JB, Spain DA, Greco RS. Differential contribution of pulmonary alveolar macrophages (PAM), interstitial macrophages (PIM) and type 2 pneumocytes (T2P) to lung injury and inflammation. J Leukocyte Biol. 1988; 44: 305
- Dorinsky PM, Costello JL, Gadek JE. Oxygen distribution and utilization after phorbol myristate acetate-induced lung injury. Am Rev Respir Dis. 1988; 138: 1454–1463
- St John RC, Mizer LA, Weisbrode SE, Dorinsky PM. Increased intestinal permeability in a model of lung injury induced by phorbol myristate acetate. Am Rev Respir Dis. 1991; 144: 1171–1176
- Sirak AA, Beavis AJ, Robertson FM. Enhanced hydroperoxide production by peripheral blood leukocytes following exposure of murine epidermis to 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis 1991; 12: 91–95
- Shapiro L, Gelfand J. Cytokines and sepsis: pathophysiology and therapy. New Horizons. 1993; 1: 13–22
- Fong Y, Moldawer L, Shires T. The biologic characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet. 1990; 170: 363–378
- Matsushima K, Morshita T, Yoshimura S. Molecular cloning of a human monocyte derived neutrophil chemotactic factor (MDNCF) and the induction of MDCNF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med. 1988; 167: 1883–1893
- Matsushima K, Oppenheim JJ. Interleukin-8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine. 1989; 1: 2–13
- Dinarello CA. Interleukin-1 and the pathogenesis of the acute phase response. New Engl J Med. 1984; 311: 1413–1418
- Dinarello CA. Interleukin-1. Rev Infect Dis. 1984; 6: 51–95
- Dinarello CA. The biology of interleukin-1. Imerleukins: Molecular Biology and Immunology. Chem Immunol, T Kishimoto. Karger, Basel 1992; 51 1–32
- Eden E, Turino GM. Interleukin-1 secretion from human alveolar macrophages in lung disease. J Clin Immunol. 1986; 6: 326–333
- Miossec P, Cavender D, Ziff M. Production of IL-1 by human endothelial cells. J Immunol. 1986; 7: 2486–2491
- Schindler R, Clark BD, Dinarello CA. Dissociation between Interleukin-1 mRNA and protein synthesis in human peripheral blood mononuclear cells. J Biol Chem. 1990; 265: 10232–10237
- Tiku K, Tiku ML, Skosey JL. Interleukin-1 production by human polymorphonuclear neutrophils. J Immunol. 1986; 136: 3677–3685
- Warner SJC, Auger KR, Libby P. Human interleukin-1 induces interleukin-1, II: interleukin-1 induces production of interleukin-1 by adult human vascular endothelial cells in vitro. J Immunol. 1987; 139: 1911–1917
- Yamato K, el-Hajjaoui Z, Koeffler HP. Regulation of levels of II-1 mRNA in human fibroblasts. J Cell Physiol. 1989; 139: 610–616
- Ulich TR, Guo K, del Castillo J. Endotoxin-induced cytokine gene expression, 1: expression of tumor necrosis factor mRNA in visceral organs under physiologic conditions. Am J Pathol. 1989; 134: 11–14
- Ulich TR, Guo K, Irwin B, Remick DG, Davatelis GN. Endotoxin-induced cytokine gene expression in vivo, II: regulation of tumor necrosis factor and interleukin-1 α/β expression and suppression. Am J Pathol. 1990; 137: 1173–1185
- Ulich TR, Watson LR, Yin S, Guo KZ, Wang P, del Castillo J. The intratracheal administration of endotoxin and cytokines, I: characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS, IL-1 and TNF-induced inflammatory infiltrate. Am J Pathol. 1991; 138: 1485–1496
- Ulich TR, Yin S, Guo K, del Castillo J, Eisenberg SP, Thompson RC. The intratracheal administration of endotoxin and cytokines, III: the interleukin-1 (IL-1) receptor antagonist inhibits endotoxin and IL-1 induced acute inflammation. Am J Pathol. 1991; 138: 521–524
- Ulich TR, Guo K, Yin S. Endotoxin-induced cytokine gene expression in vivo. IV: expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin initiated local acute inflammation. Am J Pathol. 1992; 141: 61–68
- Cunha F, Assreuy J, Moss D. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxemia: role of TNF-α and IL-1β. Immunology 1994; 81: 211–215
- Leon P, Redmond H, Shou J, Daly J. Interleukin 1 and its relationship to endotoxin tolerance. Arch Surg. 1992; 127: 146–151
- Lomedico PT, Gubler U, Hellman CP. Cloning and expression of murine IL-1 cDNA in Escherichia coli. Nature 1988; 312: 458
- Gray PW, Glaister D, Chen E, Goeddel DV, Pennica D. Two interleukin-1 genes in the mouse: cloning and expression of the cDNA for murine interleukin-1 beta. J Immunol. 1986; 137: 3644–3648
- Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627–1652
- Arend WP. Interleukin-1 receptor antagonist: a new member of the interleukin-1 family. J Clin Invest. 1991; 88: 1445–1451